Cargando…

Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown

Detalles Bibliográficos
Autores principales:	Lu, Yuan, Jones, Paul W., Caraballo, César, Mahajan, Shiwani, Massey, Daisy S., Ahmed, Rezwan, Bader, Eric M., Krumholz, Harlan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187866/ https://www.ncbi.nlm.nih.gov/pubmed/35690314 http://dx.doi.org/10.1016/j.cardfail.2022.05.012

Ejemplares similares

Trends in Thoracic Impedance and Arrhythmia Burden Among Patients with Implanted Cardiac Defibrillators During the COVID-19 Pandemic
por: Lu, Yuan, et al.
Publicado: (2021)

Physical Activity Among Patients With Intracardiac Remote Monitoring Devices Before, During, and After COVID-19–Related Restrictions
por: Lu, Yuan, et al.
Publicado: (2022)

Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions
por: Lu, Yuan, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Assessment of heart failure parameters by telemonitoring patients with an implantable cardioverter defibrillator
por: Fily, M, et al.
Publicado: (2022)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Think twice before implanting leads in a swimmer: challenges in lead implantation of an implantable cardioverter-defibrillator
por: Varvarousis, Dimitrios, et al.
Publicado: (2021)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience
por: Khazen, Cesar, et al.
Publicado: (2019)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

The first cardioverter defibrillator implanted in Central Africa
por: Cabral, Tantchou Tchoumi Jacques, et al.
Publicado: (2016)

Implantable cardioverter-defibrillators in congenital heart disease
por: Chubb, H., et al.
Publicado: (2016)

Tachycardia detection in modern implantable cardioverter–defibrillators
por: Brüggemann, Thomas, et al.
Publicado: (2016)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Implantable cardioverter defibrillators – the past, present and future
por: Ammannaya, Ganesh Kumar K.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37tosgvvj7gftsq07a6v6v0172